Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Centricus is a global investment firm that manages assets across several core sectors, including healthcare, technology, and financial services. While not a traditional biotechnology company, Centricus plays a significant role in the life sciences ecosystem through strategic investments and the formation of Special Purpose Acquisition Companies (SPACs) designed to take healthcare and biotech entities public. The firm focuses on identifying high-growth opportunities and providing the capital and operational expertise necessary to scale innovative medical technologies and therapeutic platforms. Centricus is known for its sophisticated approach to cross-border transactions and its ability to bridge capital from the Middle East and Europe into global healthcare markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centricus.